Proposed Denosumab Biosimilar SB16 vs Reference Denosumab in Postmenopausal Osteoporosis: Phase 3 Results Up to Month 12
拟上市的地诺单抗生物类似药SB16与参考地诺单抗治疗绝经后骨质疏松症:3期临床试验第12个月结果
期刊:Journal of Clinical Endocrinology & Metabolism
影响因子:5.1
doi:10.1210/clinem/dgae611
Langdahl, Bente; Chung, Yoon-Sok; Plebanski, Rafal; Czerwinski, Edward; Dokoupilova, Eva; Supronik, Jerzy; Rosa, Jan; Mydlak, Andrzej; Rowińska-Osuch, Anna; Baek, Ki-Hyun; Urboniene, Audrone; Mordaka, Robert; Ahn, Sohui; Rho, Young Hee; Ban, Jisuk; Eastell, Richard